Save your screen. Keep the bounds you have set, and get an email when an insider trades at a company it holds. A free account does both.
| Stock | FY | Clue Score ↑ | Market cap ↓ | Stock price ↓ | % change ↓ | PE ratio ↓ | Return on invested capital ↓ | Revenue growth 3Y ↓ | Net margin ↓ | Insider buyers 12M ↓ |
|---|---|---|---|---|---|---|---|---|---|---|
| ANTXAN2 Therapeutics, Inc. | 2025 | 37 | $166.0M | $4.40 | -5.98% | — | -56.74% | — | — | 1 |